Suboptimum use of FDA drug advisory committees
Lancet
.
2006 Dec 23;368(9554):2210.
doi: 10.1016/S0140-6736(06)69892-9.
Authors
Asa L Tapley
,
Peter Lurie
,
Sidney M Wolfe
PMID:
17189031
DOI:
10.1016/S0140-6736(06)69892-9
No abstract available
Publication types
Letter
MeSH terms
Advisory Committees / statistics & numerical data*
Advisory Committees / trends
Drug Approval
United States
United States Food and Drug Administration*